Emergent BioSolutions Inc (EBS) (Q3 2026) Earnings Call Highlights: Revenue Timing Weighs on ...
Emergent BioSolutions Inc (EBS) posted a soft $110 million third quarter on MCM delivery timing, yet raised full-year gross margin guidance by 300 basis points and cut gross debt to $514 million. Related Stocks: EBS ,